Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 794 1.14%
22 Jul 4:01 p.m.
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 8,712 Cr.
  • Current Price ₹ 794
  • High / Low ₹ 1,107 / 720
  • Stock P/E 74.3
  • Book Value ₹ 249
  • Dividend Yield 0.31 %
  • ROCE 7.48 %
  • ROE 4.60 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 18.6% CAGR over last 5 years

Cons

  • Stock is trading at 3.20 times its book value
  • Company has a low return on equity of 7.00% over last 3 years.
  • Company has high debtors of 176 days.
  • Promoter holding has decreased over last 3 years: -4.17%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
272 234 249 266 325 310 314 296 371 288 317 215 308
209 173 185 191 220 213 219 206 279 210 226 151 235
Operating Profit 63 60 63 75 105 97 95 89 92 78 91 64 74
OPM % 23% 26% 25% 28% 32% 31% 30% 30% 25% 27% 29% 30% 24%
3 4 6 5 -8 -13 -5 -4 18 10 4 1 11
Interest 19 7 5 5 14 12 16 14 20 18 20 25 25
Depreciation 13 14 15 16 15 16 16 17 17 17 18 18 18
Profit before tax 33 44 50 60 67 57 58 54 74 54 57 22 42
Tax % 33% 27% 28% 36% 33% 34% 29% 29% 30% 35% 32% 29% 32%
22 32 36 38 45 37 41 39 51 35 39 15 28
EPS in Rs 2.22 3.20 3.59 3.79 4.50 3.73 4.11 3.61 4.77 3.24 3.60 1.40 2.58
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
107 228 273 288 288 343 502 529 811 1,074 1,284 1,129
86 179 204 208 218 269 408 394 618 770 917 822
Operating Profit 21 49 69 80 70 73 93 134 193 304 367 307
OPM % 19% 22% 25% 28% 24% 21% 19% 25% 24% 28% 29% 27%
0 2 5 8 11 6 19 11 26 7 2 26
Interest 8 22 14 21 21 15 24 45 69 31 62 87
Depreciation 3 5 10 13 15 18 23 29 52 60 66 72
Profit before tax 10 24 50 54 45 48 66 71 99 220 242 174
Tax % 30% 23% 28% 21% 22% 19% 24% 26% 30% 32% 30% 32%
7 18 36 43 35 39 50 53 70 151 169 117
EPS in Rs 7.29 18.45 7.27 8.53 6.96 7.73 10.05 10.60 7.00 15.04 15.69 10.69
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 7% 7% 16% 7%
Compounded Sales Growth
10 Years: 17%
5 Years: 18%
3 Years: 12%
TTM: -12%
Compounded Profit Growth
10 Years: 20%
5 Years: 19%
3 Years: 19%
TTM: -30%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 1%
1 Year: -19%
Return on Equity
10 Years: 8%
5 Years: 7%
3 Years: 7%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 10 10 50 50 50 50 50 50 100 100 107 110
Reserves 23 61 58 97 194 382 432 515 1,473 1,624 2,252 2,627
56 117 144 279 318 449 687 846 423 836 822 1,067
20 29 51 55 70 97 145 252 300 325 388 547
Total Liabilities 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351
45 90 145 259 313 379 682 978 1,116 1,203 1,240 1,277
CWIP 1 1 21 64 88 250 183 101 42 43 113 579
Investments 1 0 2 2 2 2 0 0 0 148 158 159
61 126 134 157 230 347 449 583 1,137 1,492 2,057 2,336
Total Assets 109 217 303 481 632 978 1,314 1,663 2,295 2,886 3,569 4,351

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
10 51 68 69 17 -8 42 95 1 -171 244 22
-8 -38 -88 -168 -93 -247 -261 -178 -192 -412 -478 -362
-1 11 9 100 73 254 209 102 416 384 376 398
Net Cash Flow 0 24 -10 0 -3 -0 -9 19 224 -199 142 58

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 45 48 36 28 71 94 88 89 92 95 106 176
Inventory Days 252 153 158 211 305 411 277 513 528 849 626 849
Days Payable 81 56 92 94 156 148 105 225 213 223 202 332
Cash Conversion Cycle 216 144 101 144 220 358 260 378 407 721 530 692
Working Capital Days 151 120 86 113 152 207 167 184 232 327 302 431
ROCE % 29% 22% 13% 9% 9% 9% 10% 11% 11% 7%

Shareholding Pattern

Numbers in percentages

4 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
65.40% 65.40% 65.18% 65.17% 65.16% 60.96% 60.80% 60.77% 60.73% 61.41% 61.26% 61.23%
5.87% 5.73% 5.73% 4.98% 4.59% 8.19% 8.52% 9.79% 10.26% 9.13% 8.07% 7.14%
3.32% 3.75% 3.68% 4.40% 4.40% 6.18% 4.98% 3.74% 1.76% 2.51% 2.56% 2.56%
25.42% 25.12% 25.41% 25.45% 25.84% 24.67% 25.68% 25.71% 27.25% 26.96% 28.10% 29.06%
No. of Shareholders 71,45460,62965,07165,87071,49273,32666,50761,50461,12960,08957,62362,218

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls